E Nizankowska
- Physiology top 5%
- Pharmacology top 2%
- Pulmonary and Respiratory Medicine top 10%
- Immunology and Allergy top 5%
- Rheumatology top 10%
- Co-authors
- Andrzej SzczeklikMariusz DuplagaOn Behalf Of The Cannulate Tavr Expanded InvestigatorsGrażyna BochenekFilip MejzaKrzysztof NagrabaMonika ŚwierczyńskaA. Arnaud
- Topics
- Asthma and respiratory diseases (8 papers)Drug-Induced Adverse Reactions (8 papers)Inflammatory mediators and NSAID effects (7 papers)
- Partner nations
- PolandUnited StatesFrance
In The Last Decade
E Nizankowska
13 papers receiving 688 citations
Peers
Comparison fields: 5 of 66
- Physiology 513
- Pharmacology 456
- Pulmonary and Respiratory Medicine 213
- Immunology and Allergy 142
- Rheumatology 97
Countries citing papers authored by E Nizankowska
This map shows the geographic impact of E Nizankowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Nizankowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Nizankowska more than expected).
Fields of papers citing papers by E Nizankowska
This network shows the impact of papers produced by E Nizankowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Nizankowska. The network helps show where E Nizankowska may publish in the future.
Co-authorship network of co-authors of E Nizankowska
This figure shows the co-authorship network connecting the top 25 collaborators of E Nizankowska. A scholar is included among the top collaborators of E Nizankowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Nizankowska. E Nizankowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 133 | |
| 3 | 410 | |
| 4 | 74 | |
| 5 | 7 | |
| 6 | 16 | |
| 7 | 5 | |
| 8 | The effect of prostacyclin on asthma precipitated by aspirin. | 4 |
| 9 | 3 | |
| 10 | 2 | |
| 11 | 69 | |
| 12 | [Alpha-1 antitrypsin level and phenotype Pi in healthy subjects and patients with asthma]. | 1 |
| 13 | [Puerperal cardiomyopathy--a report of 2 cases]. | 1 |
About E Nizankowska
E Nizankowska is a scholar working on Pharmacology, Anesthesiology and Pain Medicine and Physiology, having authored 13 papers that have together received 738 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (8 papers), Drug-Induced Adverse Reactions (8 papers) and Inflammatory mediators and NSAID effects (7 papers). The work is most often cited by research in Pharmacology (456 citations), Immunology and Allergy (142 citations) and Otorhinolaryngology (90 citations). E Nizankowska has collaborated with scholars based in Poland, United States and France. Frequent co-authors include Andrzej Szczeklik, Mariusz Duplaga, On Behalf Of The Cannulate Tavr Expanded Investigators, Grażyna Bochenek, Filip Mejza, Krzysztof Nagraba, Monika Świerczyńska, A. Arnaud, M. Senft and D. Vervloët. Their work appears in journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and Allergy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.